The UFMylation pathway is impaired in Alzheimer's disease.

Though not quite significant, there were trends towards higher insoluble UFSP2 levels in the temporal cortex of AD patients compared to controls ( P = 0.050), and towards higher levels of insoluble UFM1 in the temporal cortex of AD patients, which also approached significance ( P = 0.062) (Table 1 ).

also in 506 other papers